<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04992416</url>
  </required_header>
  <id_info>
    <org_study_id>KD/18/20</org_study_id>
    <nct_id>NCT04992416</nct_id>
  </id_info>
  <brief_title>Immediately Placed Implants Using Simvastatin and Autogenous Tooth Graft Combination in Periodontally Compromised Sites</brief_title>
  <official_title>Immediately Placed Implants Using Simvastatin and Autogenous Tooth Graft Combination in Periodontally Compromised Sites: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kafrelsheikh University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kafrelsheikh University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, autogenous tooth graft (ATG) made from compromised teeth was applied in bone&#xD;
      defects and resulted in a good clinical efficacy.(6) Moreover, it is more accepted by&#xD;
      patients to use extracted teeth as a bone graft material, especially in the case of immediate&#xD;
      implant placement. Simvastatin (SMV), known as a 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA)&#xD;
      reductase inhibitor, is widely used to decrease serum cholesterol because of its safe and&#xD;
      effective treatment. Apart from cholesterol-lowering effects, SMV is also found to promote&#xD;
      osteogenic differentiation of bone marrow stem cells (BMSCs), suppress osteoclastic&#xD;
      differentiation in bone tissue and promotes osseointegration around implants in animal&#xD;
      studies. SMV is reported to enhance autophagy and alleviates the ROS of BMSCs in the&#xD;
      osseointegration of implants. The present study will be carried out to evaluate the effect of&#xD;
      SMV combined with ATG on bone formation around immediately placed dental implants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 2, 2020</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical evaluation of bone formation around immediately placed dental implants</measure>
    <time_frame>9 months</time_frame>
    <description>Changes on bone formation using ATBG with or without SMV around immediately placed dental implants in periodontally compromised teeth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>radiographic outcome around immediately placed dental implants</measure>
    <time_frame>9 months</time_frame>
    <description>the radiographic outcome of ATBG on bone formation with or without SMV around immediately placed dental implants in periodontally compromised teeth</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Autogenous Tooth Bone Graft</condition>
  <condition>Immediate Implant Placement</condition>
  <condition>Simvastatin</condition>
  <arm_group>
    <arm_group_label>SMV with ATBG around implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SMV mixed with ATBG around immediately placed dental implants in the extraction sockets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ATBG around implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ATBG around immediately placed dental implants in the extraction sockets</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>immediate implant placement with ATBG and SMV</intervention_name>
    <description>immediate implant placement using ATBG as a graft material, with SMV</description>
    <arm_group_label>SMV with ATBG around implant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>immediate implant placement with ATBG</intervention_name>
    <description>immediate implant placement using ATBG as a graft material without SMV</description>
    <arm_group_label>ATBG around implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Teeth need to be extracted for periodontal reasons with a defect of labial bone&#xD;
             (horizontal or vertical bone defect).&#xD;
&#xD;
          -  the teeth without acute inflammation.&#xD;
&#xD;
          -  no uncontrolled systemic disease which is not suitable for implantation.&#xD;
&#xD;
          -  Good systemic and oral health.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with systemic diseases or medications known to alter healing processes.&#xD;
&#xD;
          -  Psychiatric disorders.&#xD;
&#xD;
          -  Root canal treated teeth.&#xD;
&#xD;
          -  patients undergoing or who had undergone radiation therapy and chemotherapy to the&#xD;
             head and neck region during 12 months.&#xD;
&#xD;
          -  patients with para-functional habits.&#xD;
&#xD;
          -  alcoholics.&#xD;
&#xD;
          -  drug abusers.&#xD;
&#xD;
          -  heavy smokers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dalia R Issa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kafrelsheikh University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Dentistry, Kafrelsheikh University</name>
      <address>
        <city>Kafr Ash Shaykh</city>
        <zip>33511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 1, 2021</study_first_submitted>
  <study_first_submitted_qc>August 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2021</study_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kafrelsheikh University</investigator_affiliation>
    <investigator_full_name>Dalia Rasheed Issa</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

